PuSH - Publikationsserver des Helmholtz Zentrums München: Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Buchner, J.A.* ; Kofler, F. ; Mayinger, M.* ; Christ, S.M.* ; Brunner, T.B.* ; Wittig, A.* ; Menze, B.* ; Zimmer, C.* ; Meyer, B.* ; Guckenberger, M.* ; Andratschke, N.* ; El Shafie, R.A.* ; Debus, J.* ; Rogers, S.* ; Riesterer, O.* ; Schulze, K.* ; Feldmann, H.J.* ; Blanck, O.* ; Zamboglou, C.* ; Ferentinos, K.* ; Bilger-Zähringer, A.* ; Grosu, A.L.* ; Wolff, R.* ; Piraud, M. ; Eitz, K.A. ; Combs, S.E. ; Bernhardt, D.* ; Rueckert, D.* ; Wiestler, B.* ; Peeken, J.C.

Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy.

Neuro. Oncol. 26, 1638-1650 (2024)

Verlagsversion

Postprint

DOI

PMC

	Open Access Hybrid

Abstract
Metriken
Zusatzinfos

BACKGROUND: Surgical resection is the standard of care for patients with large or symptomatic brain metastases (BMs). Despite improved local control after adjuvant stereotactic radiotherapy, the risk of local failure (LF) persists. Therefore, we aimed to develop and externally validate a pre-therapeutic radiomics-based prediction tool to identify patients at high LF risk. METHODS: Data were collected from A Multicenter Analysis of Stereotactic Radiotherapy to the Resection Cavity of Brain Metastases (AURORA) retrospective study (training cohort: 253 patients from two centers; external test cohort: 99 patients from five centers). Radiomic features were extracted from the contrast-enhancing BM (T1-CE MRI sequence) and the surrounding edema (FLAIR sequence). Different combinations of radiomic and clinical features were compared. The final models were trained on the entire training cohort with the best parameter set previously determined by internal 5-fold cross-validation and tested on the external test set. RESULTS: The best performance in the external test was achieved by an elastic net regression model trained with a combination of radiomic and clinical features with a concordance index (CI) of 0.77, outperforming any clinical model (best CI: 0.70). The model effectively stratified patients by LF risk in a Kaplan-Meier analysis (p < 0.001) and demonstrated an incremental net clinical benefit. At 24 months, we found LF in 9% and 74% of the low and high-risk groups, respectively. CONCLUSIONS: A combination of clinical and radiomic features predicted freedom from LF better than any clinical feature set alone. Patients at high risk for LF may benefit from stricter follow-up routines or intensified therapy.

Impact Factor

Scopus SNIP

Altmetric

16.400

0.000